2022
DOI: 10.1590/1806-9282.20220078
|View full text |Cite
|
Sign up to set email alerts
|

Self-reported symptoms and seroprevalence against SARS-CoV-2 in the population of Mato Grosso: a household-based survey in 2020

Abstract: Government of the State of Mato Grosso, which provided the diagnostic tests and structure for laboratory analysis, as well as, together with the UFMT and UNEMAT, provided servers for coordination, logistics, and dissemination of results.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
(31 reference statements)
0
1
0
Order By: Relevance
“…Previous studies in Brazil have reported a wide range of olfactory dysfunction prevalence in COVID-19, ranging from 13.1 to 83.9% [19‒23]. However, these studies were based on relatively small cohorts, which may not have been representative of the entire population.…”
Section: Introductionmentioning
confidence: 99%
“…Previous studies in Brazil have reported a wide range of olfactory dysfunction prevalence in COVID-19, ranging from 13.1 to 83.9% [19‒23]. However, these studies were based on relatively small cohorts, which may not have been representative of the entire population.…”
Section: Introductionmentioning
confidence: 99%
“…In the first wave of the disease in 2020, the maximum number of cases was recorded in July, with weeks of maximum occupancy of the number of beds, in 2021, the sec-ond wave again caused the collapse of the Health System, with a queue of waiting for ICU beds between March and May 9 . In addition, through the same survey, it was found that 40% of cases were asymptomatic 10 and more than half of the population reported having used ivermectin to prevent COVID-19 11 , medicine included in the COVID Kit adopted by the state government and distributed to cases diagnosed in the Unified Health System 12 , even without having efficacy against COVID-19.…”
Section: Introductionmentioning
confidence: 99%